Key result
An Enhanced Recovery After Surgery program in patients over 75 undergoing oesophagectomy reduced 30-day mortality from 6.2% to 0% compared to the prior period.
Why the study?
Does an Enhanced Recovery after Surgery (ERAS) program improve outcomes and reduce length of stay in patients aged over 75 undergoing oesophagectomy?
Cohort (n=147)
No
Does an Enhanced Recovery after Surgery (ERAS) program improve outcomes and reduce length of stay in patients aged over 75 undergoing oesophagectomy?
In patients over 75 undergoing oesophagectomy, an ERAS program significantly reduces length of hospital stay and 30-day mortality.
Answers are grounded in this paper and cite their sources.
ERAS was associated with lower mortality in elderly oesophagectomy patients; leaves open need for randomized confirmation before practice change.
AIMS: Surgical resection is often the only curative treatment for oesophageal cancer. The aim of this retrospective cohort study was to analyse outcomes following oesophageal resection in patients aged 75 years and older and the impact of an Enhanced Recovery after Surgery (ERAS) program in this cohort. METHODS: Patients aged over 75 years undergoing oesophagectomy between 2003 and 2013 were identified from a single centre using an electronic database. Data on pre-operative comorbidity, tumour stage and length of hospital stay (LOS) were collected. Complications were classified according to the Clavien-Dindo system. Thirty day, 1- and 5-year mortality rates were calculated. RESULTS: 147 patients were identified with a median age of 78.5 (IQR 76.7-80.9). 33% (n = 44) had a grade 3 complication or higher. Median LOS in hospital was 16 days (IQR 13.0-22.0). Thirty-day mortality was 3.4%, 1-year and 5-year survival was 65% and 21% respectively. 45% of patients were enrolled into an Enhanced Recovery After Surgery program and they demonstrated a significantly reduced length of stay from 18 to 14 days (p = 0.005) and 30-day mortality from 6.2% to 0% (p = 0.04) compared to the time period before the program. CONCLUSION: Long-term survival is achievable in patients aged over 75 years.
No takes yet. Share an insight, caveat, or question.
Oakley et al. (2016) conducted a cohort in Oesophageal cancer (n=147). Enhanced Recovery After Surgery (ERAS) program vs. Time period before the ERAS program was evaluated on 30-day mortality (p=0.04). An Enhanced Recovery After Surgery program in patients over 75 undergoing oesophagectomy reduced 30-day mortality from 6.2% to 0% compared to the prior period.
Synapse has enriched 10 related papers. Consider them for comparative context: